Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.98 USD | +0.22% | -6.56% | -41.15% |
Mar. 07 | Herbalife Appoints Back Michael Levitt to Board of Directors | CI |
Feb. 16 | Big Lots, Children's Place Jump on Investor Stakes -- Consumer Roundup | DJ |
Chart calendar Herbalife Ltd.
Upcoming events on Herbalife Ltd.
Past events on Herbalife Ltd.
2024-02-14 05:30 pm | Q4 2023 Earnings Call |
2024-02-14 04:24 pm | Q4 2023 Earnings Release |
2023-11-01 05:30 pm | Q3 2023 Earnings Call |
2023-11-01 04:10 pm | Q3 2023 Earnings Release |
2023-08-02 | International Workshop on Molecular Authentication of Chinese Medicinal Material & Polymerase Chain |
2023-08-02 05:30 pm | Q2 2023 Earnings Call |
2023-08-02 04:10 pm | Q2 2023 Earnings Release |
2023-07-20 | American Society for Nutrition Meetin |
2023-07-18 | International Conference on Adaptations and Nutrition in Sports |
2023-07-11 | IDEA World Convention |
2023-07-03 | Nutrition Society of Malaysia Scientific Conference |
2023-06-17 | US-China Dietary Supplements, Health Foods and Herbal Medicines Conference - Zheng Qunyi |
2023-05-02 05:30 pm | Q1 2023 Earnings Call |
2023-05-02 04:10 pm | Q1 2023 Earnings Release |
2023-04-26 | California Academy of Nutrition and Dietetics Conference - Donna Webster |
2023-04-26 11:30 am | Annual General Meeting |
2023-04-15 | American Association for Laboratory Accreditation Conference - Isaac Lee |
2023-04-13 | Fitness Fest Arizona Conference - Samantha Clayton |
2023-04-11 | Council for Responsible Nutrition Toxicology Conference - Kristy Appelhans |
2023-04-03 | AHPA Post Market Surveillance & Adverse Event Reports Conference - Kristy Appelhans |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4 877 4 942 -1.32% | 5 542 5 564 -0.39% | 5 803 5 852 -0.84% | 5 204 5 103 1.98% | 5 062 5 036 0.53% | 5 090 |
EBITDA Million USD | Released Forecast Spread | 723 717 0.85% | 870 848 2.58% | 874 909 -3.89% | 695 664 4.57% | 571 566 0.89% | 558 |
EBIT Million USD | Released Forecast Spread | 625 619 1.02% | 770 750 2.68% | 766 778 -1.52% | 579 476 21.59% | 457 433 5.59% | 432 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 451 478 -5.58% | 516 535 -3.48% | 561 589 -4.83% | 425 378 12.38% | 203 226 -10.18% | 228 |
Net income Million USD | Released Forecast Spread | 311 325 -4.22% | 373 394 -5.36% | 447 467 -4.29% | 321 201 59.79% | 142 184 -22.68% | 205 |
EPS USD | Released Forecast Spread | 2,20 2,29 -3.93% | 2,77 2,95 -6.1% | 4,13 4,29 -3.62% | 3,23 2,94 9.86% | 1,42 1,69 -15.73% | 2,05 |
Announcement Date | 18/02/20 | 17/02/21 | 23/02/22 | 14/02/23 | 14/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1 318 1 364 -3.4% | 1 336 1 383 -3.41% | 1 393 1 306 6.64% | 1 295 1 309 -1.06% | 1 181 1 130 4.47% | 1 252 1 205 3.89% | 1 314 1 277 2.87% | 1 281 1 252 2.32% | 1 215 1 188 2.24% | 1 240 | 1 322 | 1 294 | 1 233 | 1 269 |
EBITDA Million USD | Released Forecast Spread | 132 142 -7.55% | 186 177 5.07% | 195 146 33.56% | 183 164 11.46% | 131 98,7 32.39% | 129 150 -13.89% | 170 155 9.22% | 163 162 1.08% | 109 119 -8.73% | 125 | 161 | 157 | 115 | 135 |
EBIT Million USD | Released Forecast Spread | 104 119 -12.64% | 156 152 2.89% | 166 114 45.7% | 154 134 15.07% | 103 72,3 41.75% | 101 111 -8.74% | 141 127 10.29% | 135 133 1.21% | 80,6 90,7 -11.15% | 94,4 | 129 | 125 | 83,0 | 102 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 47,6 76,2 -37.49% | 123 110 11.98% | 124 82,5 50.52% | 113 92,0 22.72% | 64,4 18,0 257.78% | 31,1 70,0 -55.57% | 85,0 84,4 0.77% | 69,2 91,8 -24.59% | 17,7 47,7 -62.85% | 50,5 | 77,9 | 74,5 | 25,3 | 64,7 |
Net income Million USD | Released Forecast Spread | 38,2 58,3 -34.42% | 98,2 85,5 14.92% | 86,5 63,0 37.41% | 82,2 72,0 14.17% | 54,4 25,2 115.68% | 29,3 55,0 -46.73% | 59,9 66,5 -9.92% | 42,8 71,9 -40.47% | 10,2 36,4 -71.97% | 43,8 | 67,5 | 62,5 | 30,9 | 48,0 |
EPS USD | Released Forecast Spread | 0,37 0,55 -32.73% | 0,96 0,84 14.97% | 0,88 0,63 39.68% | 0,83 0,74 12.16% | 0,55 0,26 115.69% | 0,29 0,65 -55.04% | 0,60 0,66 -9.55% | 0,43 0,72 -40.48% | 0,10 0,37 -72.6% | 0,44 | 0,68 | 0,63 | 0,31 | 0,48 |
Announcement Date | 23/02/22 | 03/05/22 | 02/08/22 | 31/10/22 | 14/02/23 | 02/05/23 | 02/08/23 | 01/11/23 | 14/02/24 | - | - | - | - | - |
Past sector events for Herbalife Ltd.
Today | BYHEALTH CO., LTD: Q4 2023 Earnings Release |
Today | CK LIFE SCIENCES INT'L., (HOLDINGS) INC.: Q4 2023 Earnings Release |
2024-03-14 | CSPC INNOVATION PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-03-13 04:15 pm | JAMIESON WELLNESS INC.: Q4 2023 Earnings Release |
2024-02-27 01:32 am | GRAPE KING BIO LTD: Q4 2023 Earnings Release |
2024-02-20 04:05 pm | MEDIFAST, INC.: Q4 2023 Earnings Release |
2024-02-15 01:30 am | GRAPE KING BIO LTD: January 2024 Sales and Revenue Release |
2024-02-14 04:24 pm | HERBALIFE LTD.: Q4 2023 Earnings Release |
2024-02-13 | EUGLENA CO., LTD.: Q4 2023 Earnings Release |
2024-02-13 | EUGLENA CO., LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Herbalife Ltd. - Nyse
- Calendar Herbalife Ltd.